Withdrawal from benzodiazepines by initially switching to zopiclone
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Summary: Withdrawal from hypnotics can produce a variety of problems, especially sleep difficulties, some of which may arise from the multiple actions of most hypnotics, thus producing a range of rebound effects. This study examined whether switching patients to a hypnotic with a narrower range of action and of a different class would reduce these problems. One hundred and thirty-four patients participated; they were randomly allocated to one of three methods of switching from “previous hypnotic” to zopiclone (a cyclopyrrolone). The methods were gap (an interval between taking the two drugs); abuttal (taking zopiclone immediately on stopping previous drug); and overlap (gradually reducing previous drug after starting zopiclone). The main findings were that zopiclone was associated with better sleep and increased alertness; the abuttal method was the best method of switching; and no serious side effects from zopiclone were reported. It was concluded that zopiclone has a useful role in benzodiazepine withdrawal, and that immediate substitution is the best method.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insomnia and Its Treatment: Prevalence and Correlates
Mellinger, G. D. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790260019002 · Cited by 1,071 · cited 1×
“Hypnotic medication is commonly prescribed for insomnia, and about one in forty adults abuse hypnotic medication in a one year period (Mellinger et al, 1985); although intended as an acute intervention, hypnotic use often becomes chronic, but after some time the effectiveness is severely reduced.”
BackgroundBenzodiazepine withdrawal: outcome in 50 patients
ASHTON, H. (1987) · British Journal of Addiction · doi:10.1111/j.1360-0443.1987.tb01529.x · Cited by 160 · cited 1×
“…from lorazepam had greater withdrawal problems than those withdrawing from diazepam or bromazepam, perhaps because lorazepam was the most potent; it is important to note that suicide has occasionally been reported in connection with lorazepam withdrawal (Murphy and Tyrer, 199 1; Ashton, 1987).”
BackgroundMurphy, S. M., & Tyrer, P. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.158.4.511 · Cited by 104 · cited 1×
“In a recent random allocation study with 68 patients, Murphy and Tyrer (1991) found that patients with- drawing from lorazepam had greater withdrawal problems than those withdrawing from diazepam or bromazepam, perhaps because lorazepam was the most potent; it is important to note that suicide has…”
BackgroundEffect of Gradual Withdrawal on the Rebound Sleep Disorder after Discontinuation of Triazolam
Greenblatt, D. J., Harmatz, J. S., Zinny, M. A., & Shader, R. I. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709173171202 · Cited by 96 · cited 1×
“Most withdrawal studies employ a gradual reduction of hypnotics, but this may not be sufficient to reduce or eliminate withdrawal reactions (Greenblatt et al, 1987).”
Background
Cited by
Noble, S., Langtry, H. D., & Lamb, H. M. (1998) · Drugs · doi:10.2165/00003495-199855020-00015 · Cited by 254
Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline.
(2018) · Europe PMC (PubMed Central) · Cited by 250
Lemoine, P., Kermadi, I., Garcia-Acosta, S., Garay, R. P., & Dib, M. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.015 · Cited by 180
(2003) · Europe PMC (PubMed Central) · Cited by 176
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
Baandrup, L., Ebdrup, B. H., Rasmussen, J. Ø., Lindschou, J., Gluud, C., & Glenthøj, B. Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011481.pub2 · Cited by 128
Metadata
- Authors
- Shapiro, C., Sherman, D., & Peck, D.
- Venue
- European Psychiatry
- Publisher
- Cambridge University Press (CUP)
- Published
- 1995
- Volume
- 10
- Issue
- S3
- Pages
- 145s-151s
- ISSN
- 0924-9338 (ISSN-L)
- 1778-3585
- OpenAlex
- W2072672004
- Cited by
- 25
- References
- 4
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Withdrawal from benzodiazepines by initially switching to zopiclone. https://app.cochat.ai/papers/10.1016/0924-9338(96)80096-4
- The paper
- Shapiro, C., Sherman, D., & Peck, D. (1995). Withdrawal from benzodiazepines by initially switching to zopiclone. European Psychiatry. https://doi.org/10.1016/0924-9338(96)80096-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.